The India government broke silence Thursday over the four contaminated syrups that caused the death of 66 children, saying these products were only sold to Gambia.
“From the preliminary enquiry of Central Drugs Standard Control Organisation (CDSCO), it has been made out that Maiden Pharmaceutical Limited, Sonepat, Haryana is a manufacturer licensed by the State Drug Controller for the products Promethazine Oral Solution BP, Kofexnalin Baby Cough Syrup, Makoff Baby Cough Syrup and MaGrip n Cold Syrup under reference, and holds manufacturing permission for these products for export only,” the Union Ministry of Health said in a statement obtained by JollofNews.
The tiny West African nation has been hit by an acute kidney injury (AKI) outbreak that took dozens of young lives. Consequently, the World Health Organization (WHO) Director General, Tedros Adhanom Ghebreyesus, sounded the alarm bell Wednesday, adding that the contaminated medicines “have been potentially linked to AKI.”
India’s Ministry of Health unequivocally stated that the “company has manufactured and exported these products only to Gambia.”
Shifting the axis of contradiction, the India government almost tried to wash its hands over a matter that continues to generate headlines across the world.
“It is a usual practice that the importing country tests these imported products on quality parameters, and satisfies itself as to the quality of the products before the importing country decides to release such products for usage in the country,” the statement said.
As calls are intensifying for Maiden Pharmaceutical Limited to be held accountable for the death of 66 children in the country, President Adama Barrow is expected to address the nation Friday after meeting Health experts.
